The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.
about
A functional CFTR assay using primary cystic fibrosis intestinal organoidsInvestigating CFTR and KCa3.1 Protein/Protein InteractionsRectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility.Increased cystic fibrosis transmembrane conductance regulators expression and decreased epithelial sodium channel alpha subunits expression in early abortion: findings from a mouse model and clinical cases of abortion.CFTR regulates early pathogenesis of chronic obstructive lung disease in βENaC-overexpressing miceMeasurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis.Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients.CFTR is a tumor suppressor gene in murine and human intestinal cancerAromatic-aromatic interactions between residues in KCa3.1 pore helix and S5 transmembrane segment control the channel gating process.Repairing the basic defect in cystic fibrosis - one approach is not enough.Individualized medicine using intestinal responses to CFTR potentiators and correctors.Purinergic regulation of CFTR and Ca(2+)-activated Cl(-) channels and K(+) channels in human pancreatic duct epithelium.Novel opportunities for CFTR-targeting drug development using organoids.Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis.
P2860
Q28291898-B971FBE3-6B5C-4F38-B5B6-36542B472EBFQ29147472-52712A3F-B89C-420D-9228-CB3E749D063DQ30540580-17A95166-0180-42A4-B5C3-16502C7C97E6Q33734646-ED520501-9848-4E56-BBA6-8725C2932409Q34399667-30E6BE99-DCC3-4829-835D-CB3820F38D36Q34452224-2B5CC6F0-FA8B-45BB-833B-506625352544Q35286065-97B81B47-9240-4A72-ADB9-494B48BC8D5DQ37083588-655D0396-046F-4B6B-8D9A-29728CA08BEFQ37727041-41C19081-DE87-4120-92E2-DB46A29A78B6Q38594795-4C70BF85-3272-4BCF-87E8-5D068864204FQ38962735-EA6108DD-1DFF-46F0-A35E-733A0F510064Q39201947-78167695-67F0-431B-BDD1-6E6949CC1BE1Q39496065-B2EFED06-7C2F-4FFD-BEC2-299ED41B1923Q41302801-42D13D6B-BDB0-4091-863D-02DB303502CDQ43817116-52F22AE8-4F34-49F6-A979-83516E689C60
P2860
The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@ast
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@en
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@nl
type
label
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@ast
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@en
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@nl
prefLabel
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@ast
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@en
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@nl
P2093
P2860
P1433
P1476
The K+ channel opener 1-EBIO p ...... from cystic fibrosis patients.
@en
P2093
Daniel Wenning
Eva K Roth
Hans H Seydewitz
Irmgard Eichler
Julia Duerr
Marcus A Mall
Margarida D Amaral
Stephanie Hirtz
P2860
P304
P356
10.1371/JOURNAL.PONE.0024445
P407
P577
2011-08-31T00:00:00Z